Showing results (311-320 of 323) with videos related to

Sort By:
Pageof 33
Neuro-Oncology|August 12, 2025
The Role of Radiotherapy in MPNST and the Impact of NF1 Status on Outcomes: Insights From A Multicenter Cohort StudyChristianne Y M N Jansma, Dirk J Grünhagen, Uta E Flucke, et al.
The Lancet. Infectious Diseases|August 4, 2024
Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trialAhmed H Fahal, Eiman Siddig Ahmed, Sahar Mubarak Bakhiet, et al.
The Journal of Bone and Joint Surgery. American Volume|October 7, 2020
Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 CasesE M Schutgens, P Picci, D Baumhoer, et al.
Head & Neck|June 30, 2025
Health-Related Quality of Life in Patients With a Head and Neck Sarcoma: A Mixed-Methods StudyE Koffi, C S Padilla, C Drabbe, et al.
The Bone & Joint Journal|January 31, 2025
Two-stage revision for infection of oncological megaprostheses : a multicentre EMSOS studyAndrea Sambri, Domenico A Campanacci, Elisa Pala, et al.
The Bone & Joint Journal|August 31, 2025
Grade 2 central chondrosarcoma treated by intralesional curettage: observation or surgery? : a multicentre retrospective studyAndrea Sambri, Domenico Andrea Campanacci, Minna K Laitinen, et al.
Neuro-Oncology Advances|July 1, 2024
Survival after resection of malignant peripheral nerve sheath tumors: Introducing and validating a novel type-specific prognostic modelIbtissam Acem, Ewout W Steyerberg, Marta Spreafico, et al.
Nature Communications|August 21, 2025
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibitionFemke C A S Ringnalda, Gijs J F van Son, Laurens H G Verweij, et al.
Frontiers in Pediatrics|April 30, 2025
A multidisciplinary and structured approach for comprehensive evaluation of functional outcomes, adverse events, psychosocial outcomes and health-related quality of life after local therapy for bone sarcoma in children: protocol for a cross-sectional studyLeonie G Tigelaar, Lianne M Haveman, Willem P Bekkering, et al.
Blood|August 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosisAldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, et al.
Pageof 33